CLCN2 Knockout HEK293 Cell Line

CLCN2 Knockout HEK293 Cell Line
Cat.No.:

EDC09609

Species:

Human

Cell Name:

HEK293

Gene:

CLCN2

Gene ID:

1181

Size:

1×10⁶cells

CLCN2 Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
Cat.No. EDC09609
Product Name CLCN2 Knockout Cell Line (HEK293)
Cell Line HEK293
Cellosaurus ID CVCL_0045
Cell Line Synonyms Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293
Gene CLCN2
NCBI Gene ID
Gene Synonyms CIC-2|CLC2|ECA2|ECA3|EGI11|EGI3|EGMA|EJM6|EJM8|FHA2|FHII|HALD2|LKPAT|clC-2
Summary
This gene encodes a voltage-gated chloride channel. The encoded protein is a transmembrane protein that maintains chloride ion homeostasis in various cells. Defects in this gene may be a cause of certain epilepsies. Four transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2012]
Associated Diseases Non-tumor
Morphology Adherent
Passage Ratio 1/5,2days
Complete Culture Medium DMEM + 10% FBS
Freezing Medium 95% Complete culture medium+ 5% DMSO
QC Indels validated by Sanger sequencing; sterility confirmed via microbial testing.
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
LociSTR Info (Sample Cell)
Sample Cell Line: HEK293
STR Info (Cell bank)
Cell Line: HEK293
Allele1Allele2Allele1Allele2
Amelogenin X X
CSF1P0 12 11 12
D2S1338 19 19
D3S1358 15 17 15 17
D5S818 8 8 9
D7S820 11 12 11 12
D8S1179 12 14 12 14
D13S317 12 14 12 14
D16S539 9 13 9 13
D18S51 17 18 17 18
D19S433 15 18 15 18
D21S11 28 30.2 28 30.2
FGA 23 23
Penta D 9 10 9 10
Penta E 7 15 7 15
TH01 7 9.3 7 9.3
TPOX 11 11
vWA 16 19 16 19
D6S1043 11 11
D12S391 19 21 11 15
D2S441 11 15 11 15
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.

FAQ

The choice depends on whether you are studying CLCN2 (chloride channel 2, CLC-2)'s role as a plasma membrane voltage-gated Cl⁻ channel or modeling leukoencephalopathy and CLCN2-mediated aldosteronism. The Knockout line is the standard tool for asking whether CLCN2 is required for these processes — CLCN2 is a CLC family member that, unlike CLC-7, functions as a true plasma membrane voltage-gated Cl⁻ channel activated by hyperpolarization, cell swelling, and acidic pH; CLCN2 has roles in maintaining cellular Cl⁻ homeostasis, brain extracellular ion balance, and aldosterone production. Overexpression is useful for studying CLCN2 gain-of-function effects. For neurological and endocrine research, the EDITGENE CLCN2 Knockout in HEK293 enables structure-function studies — CLCN2 biallelic loss-of-function mutations cause leukoencephalopathy with ataxia (LKPAT, brain white matter disease) and infertility; gain-of-function mutations cause familial hyperaldosteronism type II. Rescue with wild-type, channel-dead, or disease-mutant CLCN2 enables comprehensive disease modeling. The knockout is valuable for studying voltage-gated Cl⁻ channel biology, leukoencephalopathy mechanisms, and aldosterone production regulation.
Primary applications: • Voltage-gated Cl⁻ current: whole-cell patch clamp analysis of hyperpolarization-activated Cl⁻ currents in CLCN2-null cells. • LKPAT leukoencephalopathy modeling: rescue with biallelic loss-of-function patient mutations for genotype-function studies. • Familial hyperaldosteronism modeling: rescue with gain-of-function CLCN2 mutations (e.g., G24D, R172Q, Y26N) for type II hyperaldosteronism studies. • Aldosterone production: in heterologous adrenocortical-relevant contexts, CLCN2-induced membrane depolarization and aldosterone synthesis. EDITGENE recommends this model for researchers investigating voltage-gated Cl⁻ channel biology and CLCN2-related neurological/endocrine disease.
Yes. CLCN2 rescue experiments require attention to plasma membrane voltage-gated channel architecture: • Construct design: use a codon-modified CLCN2 sequence with a small intracellular tag (FLAG, HA). CLCN2 has the canonical CLC architecture — preserve membrane topology. • Surface localization validation: confirm plasma membrane localization before electrophysiology assays. • Channel-dead rescue: gating residue mutations abolish hyperpolarization-activated Cl⁻ currents. • Familial hyperaldosteronism mutation rescue: gain-of-function mutations (G24D, R172Q, Y26N) enable disease modeling. • Functional readout: rescue should restore hyperpolarization-activated Cl⁻ currents by patch clamp. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation for systematic CLCN2 mutation analysis.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.

Recommended Accessories

Related Products

Flash CRISPR Knockout Kit(Universal Version)Flash CRISPR Knockout Kit(Universal Version)
Flash-Pro CRISPR KO Kit (For Organoids / Stem Cells)Flash-Pro CRISPR KO Kit (For Organoids / Stem Cells)

Related Services

Knockout Cell LineKnockout Cell Line
Contact Us
*
*
*
*
How did you hear about us: